IXHL · Incannex Healthcare Inc. · Metrics
Market Cap
$34.62M
Shares
12.54M
Volume · Oct 20
51.04K
Avg daily vol (3M)
86.42K
IXHL metrics
54 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$2.76
Market cap
$34.62M
Price action
20 metricsPrice change (1W)
-4.8%
Price change (30D)
-20.9%
Price change (3M)
-14.0%
Price change (6M)
-28.1%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
101.7%
Annualized volatility (3M)
49.1%
Beta
1.4
RSI (14D)
29.6
Price vs SMA 50
-16.4%
Price vs SMA 200
—
Avg volume (3M)
86,415
Relative volume
0.8
Average dollar volume
$283,551
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
12.54M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.5
reciprocal yield 190.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-54.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$23.03M
Net income (TTM)
−$19.30M
Trailing 12 months
Diluted EPS (TTM)
$-1.66
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,786.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-28.6%
Return on assets
-26.4%
Debt / equity
—
Current ratio
48.8
EBITDA (TTM)
−$22.79M
Free cash flow (TTM)
—
Quick ratio
48.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$67.71M
Total assets
$72.98M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$12.87M
Capital expenditures (TTM)
—
R&D (TTM)
$5.21M
SG&A (TTM)
—
Stock compensation (TTM)
$7.56M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
15
13F filer change QoQ
-6
Institutional ownership
3.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.8%
Private-fund adviser ownership
0.9%
Active holders' share change QoQ
-65.0%
Holder tenure
4.0
Price vs estimated holder cost
-13.8%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.1%
Short interest
3 metricsShort interest
3.6%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
51 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—